Viewing Study NCT06334120


Ignite Creation Date: 2025-12-25 @ 4:25 AM
Ignite Modification Date: 2026-03-04 @ 8:45 PM
Study NCT ID: NCT06334120
Status: RECRUITING
Last Update Posted: 2025-12-05
First Post: 2024-03-21
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: An Observational Study to Learn More About the Safety of Darolutamide in Men With Prostate Cancer in Korea
Sponsor: Bayer
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-metastatic Castration-resistant Prostate Cancer View
None Metastatic Hormone-sensitive Prostate Cancer View
Keywords: